The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2004 © Crown Copyright 2004 Statutory Instruments printed from this website are printed under the superintendence and authority of the Controller of HMSO being the Queen's Printer of Acts of Parliament. The legislation contained on this web site is subject to Crown Copyright protection. It may be reproduced free of charge provided that it is reproduced accurately and that the source and copyright status of the material is made evident to users. It should be noted that the right to reproduce the text of Statutory Instruments does not extend to the Queen's Printer imprints which should be removed from any copies of the Statutory Instrument which are issued or made available to the public. This includes reproduction of the Statutory Instrument on the Internet and on intranet sites. The Royal Arms may be reproduced only where they are an integral part of the original document. The text of this Internet version of the Statutory Instrument which is published by the Queen's Printer of Acts of Parliament has been prepared to reflect the text as it was Made. A print version is also available and is published by The Stationery Office Limited as the The Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2004, ISBN 0110492218. The print version may be purchased by clicking here. Braille copies of this Statutory Instrument can also be purchased at the same price as the print edition by contacting TSO Customer Services on 0870 600 5522 or e-mail: customer.services@tso.co.uk. Further information about the publication of legislation on this website can be found by referring to the Frequently Asked Questions. To ensure fast access over slow connections, large documents have been segmented into "chunks". Where you see a "continue" button at the bottom of the page of text, this indicates that there is another chunk of text available.
As respects England, Scotland and Wales, the Secretary of State concerned with health in England, and, as respects Northern Ireland, the Department of Health, Social Services and Public Safety, acting jointly, in exercise of the powers conferred upon them by sections 58(1), (1B), (4), (4A), (4B) and (5) and 129(4) of the Medicines Act 1968[1], or, as the case may be, those conferred by the said provisions and now vested in them[2], and of all other powers enabling them in that behalf, after consulting such organisations as appear to them to be representative of interests likely to be substantially affected by this Order, pursuant to section 129(6) of that Act, and after consulting and taking into account the advice of the Committee on Safety of Medicines, pursuant to sections 58(6) and 129(7) of that Act, hereby make the following Order: Citation, commencement and interpretation 1. - (1) This Order may be cited as the Prescription Only Medicines (Human Use) Amendment (No. 2) Order 2004 and shall come into force on 18th May 2004. (2) In this Order, "the principal Order" means the Prescription Only Medicines (Human Use) Order 1997[3]. Amendment of article 1 of the principal Order 2. In article 1(2) of the principal Order (interpretation), in the appropriate alphabetical place, insert the following definitions -
Amendment of Schedule 3A to the principal Order
(b) for the entry "Hydrocortisone acetate", in column 2 add "or aural" after "External use"; (c) for the entry "hyoscine butylbromide", in column 2 omit "or transdermal" after "Parenteral"; and (d) in column 1 insert, at the appropriate place in the alphabetical order of the entries as they appear in that column, the entry set out in column 1 below, and in column 2 insert, against that entry, the corresponding entry in column 2 below -
Amendment of Schedule 5 to the principal Order
Amendment of Schedule 7 to the principal Order
(This note is not part of the Order) This Order amends the Prescription Only Medicines (Human Use) Order 1997 ("the principal Order") which specifies the description and classes of medicines ("prescription only medicines") which, subject to exemptions specified in the Order, may be sold or supplied only in accordance with the prescription of an "appropriate practitioner", and may be administered only in accordance with the directions of such a practitioner. Article 3 amends Schedule 3A to the principal Order so as to change the permitted use or route of administration for the following substances, when prescribed or administered by an extended formulary nurse prescriber: hydrocortisone acetate (to include aural use) and hyoscine butylbromide (to remove transdermal administration). Article 3 also adds hyoscine to the list of substances which may be prescribed by extended formulary nurse prescribers, subject to certain conditions. Finally, article 3 amends the reference to the substance clavulanic acid to clavulanic acid (as potassium clavulanate). These changes involve minor corrections to entries inserted by previous orders. Article 4 amends Part III of Schedule 5 of the principal Order so as to add reteplase and tenecteplase to the list of substances that may be parenterally administered by registered paramedics or persons who hold a certificate of proficiency in ambulance paramedic skills issued by, or with the approval of, the Secretary of State. Article 5 amends Part III of Schedule 7 to the principal Order by adding registered dietitians, occupational therapists, orthotists and prothetists and language and speech therapists to the list of classes of individuals who can supply or administer a prescription only medicine under a Patient Group Direction. A full regulatory impact assessment of the effect that this instrument will have on the costs of business is available from the Medicines and Healthcare products Regulatory Agency, Information Centre, Room 10-202 Market Towers, 1 Nine Elms Lane, London SW8 5NQ and a copy has been placed in the libraries of both Houses of Parliament. Notes: [1] 1968 c. 67. The expression "the appropriate Ministers" and the expression "the Health Ministers", which are relevant to the powers being exercised in the making of this Order, are defined in section 1 of that Act as amended by article 2(2) of, and Schedule 1 to, S.I. 1969/388, by article 5 of, and paragraph 1(1) of the Schedule to, S.I. 1999/3142, and by article 5(1) of, and paragraph 15 of Schedule 1 to, S.I. 2002/794; section 58 of that Act was amended by section 1 of the Prescription by Nurses etc. Act 1992 (c. 28) and by section 63 of the Health and Social Care Act 2001 (c. 15).back [2] In the case of the Secretary of State concerned with health in England, by virtue of article 2(2) of, and Schedule 1 to, S.I. 1969/388, and articles 2(1) and 5 of, and paragraph 1(1) of the Schedule to, S.I. 1999/3142; and in the case of the Department for Health, Social Services and Public Safety, by virtue of the powers vested in the Minister in charge of that Department by virtue of section 95(5) of, and paragraph 10 of Schedule 12 to, the Northern Ireland Act 1998 (c. 47) which may now be exercised by the Department by virtue of section 1(8) of, and paragraph 4(1)(b) of the Schedule to, the Northern Ireland Act 2000 (c. 1); the Department was renamed by virtue of Article 3(6) of S.I. 1999/283 (N.I.1).back [3] S.I. 1997/1830; relevant amending instruments are S.I. 2000/1917, 2002/549, 2003/696 and 2915 and 2004/2.back [5] Schedule 3A was inserted by S.I. 2002/549, and amended by S.I. 2003/696, 2003/ 2915 and 2004/2.back [6] Schedule 7 was inserted by S.I.2000/1917, and amended by S.I. 2000/2899 and 2003/1590.back
ISBN 0 11 049221 8
|
|
| ||
| We welcome your comments on this site | © Crown copyright 2004 | Prepared 27 April 2004 |